Unknown

Dataset Information

A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276.


ABSTRACT:

Background

Liver transplantation is an effective therapy for end-stage liver diseases and acute liver failure. After the operation, however, recipients may suffer grafts loss induced by alloimmune reaction, which is termed as acute allograft rejection. The interaction between costimulatory molecules, CD276, and its ligand, TREML2, promotes T cell-mediated immune response, as well as acute or chronic allograft rejection. Our research aimed at correlating genetic polymorphisms of CD276/TREML2 with acute rejection, and evaluating its prognostic value of acute rejection after liver transplantation.

Methods

The study enrolled a total of 388 recipients. Among them, acute allograft rejection was observed in 54 cases. We performed single nucleotide polymorphism genotyping of CD276,

SUBMITTER: Yu X 

PROVIDER: S-EPMC6603397 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature